
|Podcasts|August 26, 2022
Pharmacy Focus: Psychedelic Pharmacy - The Future of Ketamine
Industry partnerships will be essential to improving access to ketamine, according to expert Kevin Nicholson.
Advertisement
This month, we spoke with Kevin Nicholson, CEO of Ketamine Wellness Centers and recently-announced CEO of Delic Corp., to discuss the future of ketamine research and why industry partnerships will be crucial to improving access.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
PBM Reform Within 2026 Appropriations Bill Signed Into Law
2
Study Finds Persistent Gaps in Diagnoses for Depression and Chronic Conditions After COVID-19
3
Most Favored Nation Drug Pricing: Analysis and Implications
4
From CAR T to Gene Therapy, Pharmacists Prepare for What’s Next at the 2026 Tandem Meeting
5


























